Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PineBridge Investments is a global asset management firm focused on active, high-conviction investing across multi-asset, equities, fixed income, private credit, and real estate. The firm serves institutional and other professional investors with globally integrated investment capabilities spanning emerging and developed markets. PineBridge was formerly AIG Investments and was acquired by MetLife Investment Management in December 2025, with certain businesses excluded from the transaction, including its private equity funds group business and its China joint venture. It is not a biotechnology, pharmaceutical, healthcare, or life sciences operating company; rather, it is a financial services firm whose business centers on investment management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PineBridge Investments.